Elucid

Boston, United States

Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.

$36.5M raised

Oct 2025

Series D

Top Investors

National Science FoundationElevage Medical TechnologiesAphelion CapitalSand Hill AngelsBlueStone Venture Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Elucid raised?

Elucid has raised $36.5M in total funding. The most recent round was Series D. The last funding was announced in October 2025.

Who are Elucid's investors?

Elucid's investors include National Science Foundation, Elevage Medical Technologies, Aphelion Capital, Sand Hill Angels, BlueStone Venture Partners.

Where is Elucid headquartered?

Elucid is headquartered in Boston, United States.

What does Elucid do?

Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.

What stage is Elucid at?

Elucid is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 22, 2025.

MLA

"Elucid — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/elucid. Accessed June 4, 2026.

APA

VCBacked. (2025). Elucid — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/elucid

Wikipedia (cite web)

{{cite web |title=Elucid — Funding & Investors |url=https://www.vcbacked.co/company/elucid |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 22, 2025.